Silencing of TGFβ and Cox2 at this siRNA concentration reduced tumor, but at 43 and 50 days we see that inclusion of anti-PDL1 mAbs further reduces tumor viability compared to siRNAs alone (Figure 3C). Here, TGFB1 is linked to neoplasm.